Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Anorexia × Infliximab × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Classical hematology 1

Conditions

Colitis, Ulcerative 3 Melanoma 2 Inflammatory Bowel Diseases 2 Crohn Disease 2 Pancreatic Neoplasms 1 Lymphoma 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Cachexia 1 Arthritis, Rheumatoid 1 Anorexia 1 Anemia 1

Interventions

Megestrol Acetate 2 Infliximab 1 Gemcitabine 1 EOM613 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Centocor, Inc.

Phase 2 Completed

Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡